

































Oxidative stress is defined as an excessive accumulation 
of reactive oxygen species (ROS) beyond the capacity 
of antioxidants [1]. ROS usually emerge as superoxide 
(O2
-), which is dismutated immediately to hydrogen 
peroxide (H2O2) by superoxide dismutase (SOD). H2O2 
is further converted into water by catalase or several 
types of peroxidases, including glutathione peroxidases 
and peroxiredoxin (Prx) (thioredoxin peroxidases) [2]. 
However, this sequential conversion from O2
- to water 
is not 100% efficient. Residual O2
- acts directly as an 
oxidant or reacts immediately with NO to produce 
peroxynitrite (ONOO
–), a very harmful ROS, in NO-
producing cells, such as endothelial cells [3] and 
macrophages [4]. H2O2 is stable and diffusible, but it 
can also be converted to hydroxyradical (OH-), a potent 
oxidant, by the Fenton reaction (Fe





In  the  heart,  nearly  90% of ROS in cardiomyocytes is 
 
 
































produced by leakage of electrons from Complexes I [6] 
and III [7] of the mitochondrial electron transport chain 
(ETC) during oxidative phosphorylation, an important 
process that generates ATP [8]. Since electrons are by-
products of energy production by the ETC, O2
- 
production through this mechanism does not appear to 
be a regulated process. Although increased oxidative 
stress during heart failure is also largely mediated by 
the leakage of electrons from the mitochondrial ETC, 
whether or not the leakage of electrons is really the 
predominant source of oxidative stress in the heart 
under stress conditions remains to be elucidated. 
Besides the leakage from the ETC, ROS can be also 
generated through ROS-producing enzymes [9]. In 
particular, the NADPH oxidase family proteins  are 
unique enzymes which purposefully produce O2
- [1, 10, 
11]. An emerging hypothesis is that Nox4, a member of 
the NADPH oxidase family, is localized in 
mitochondria and actively produces ROS under 
pathological conditions and during aging [12, 13]. Here 
we  discuss  the  role  of  Nox4  in  mediating  oxidative 
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Regulation of aging and lifespan by oxidative stress 
in mitochondria 
 
Aerobic cells need antioxidants localized in 
mitochondria in order to overcome inevitable ROS pro-
duction following energy generation. A functional 
decline in the antioxidants or increased production of 
ROS in mitochondria causes accumulation of ROS, 
thereby leading to mitochondrial dysfunction. Accum-
ulation of oxidative stress in mitochondria is highly 
relevant to aging and the development of various aging-
related common diseases, including cardiovascular 
diseases. This hypothesis is referred to as the “free 
radical theory of aging” [8]. However, the involvement 
of specific forms of ROS and each antioxidant and/or 
ROS-producing enzyme in the process of aging remains 
obscure. Recently, generation of mouse models in 
which the level of specific ROS and/or enzymes 
modifying the level of ROS is altered has provided us 
with valuable information regarding the role of ROS in 
mediating aging in mammalian hearts.  
 
There are 3 forms of superoxide dismutase (SOD 1-3), 
enzymes dismutating O2
-, in mammals. SOD2 is 
localized specifically in the mitochondrial matrix. Since 
SOD2 has manganese in its reactive center, it is referred 
to as MnSOD. Systemic ablation of MnSOD in mice is 
accompanied by dilated cardiomyopathy and neurode-
generation leading to early postnatal death [14]. Cardio-
myocyte-specific deletion of MnSOD was sufficient to 
induce mitochondrial dysfunction and the development 
of dilated cardiomyopathy. In this model, mitochondrial 
O2
- content was increased by 40% while H2O2 was 
decreased by 70% [15]. Thus, this model would be 
useful for determining the role of O2
- in mediating 
mitochondrial dysfunction and aging in the heart. 
Although overexpression of MnSOD extends lifespan in 
Saccharomyces cerevisiae [16] and Drosophila melano-
gaster  [17], neither overexpression nor heterozygous 
knockout of MnSOD affects lifespan in mice [18, 19], 
suggesting that mitochondrial O2
– may not directly 
affect lifespan in mammals. However, MnSOD overex-
pression slows the replicative growth rate in human 
cancer cells [20]. Overexpression of MnSOD also 
protects the heart from mitochondrial dysfunction and 
heart failure in a mouse model of diabetic cardiomy-
opathy [21]. Thus, it is possible that O2
- may accelerate 
the aging processes by stimulating mitochondrial dys-
function in some organs and cell types.  
 
In contrast to the ambiguous effect of O2
- upon 
lifespan/aging in mammals, mitochondrial H2O2 appears 
more clearly correlated with lifespan. In transgenic mice 
overexpressing catalase in mitochondria, maximal 
lifespan was extended by 20%, and cardiac pathology 
and development of cataracts were significantly delayed 
[22]. Possible underlying mechanisms include direct 
beneficial effects of reduced oxidative stress in mito-
chondria,  i.e.  preservation of mitochondrial functions, 
and indirect effects upon cell signaling modulated by 
the redox status. Catalase is primarily localized in 
peroxisomes, and is present in mitochondria only at low 
concentrations. Thus, mitochondrially-localized peroxi-
redoxin (Prx3 and 5) may be more critical in H2O2 
detoxification [2]. Although the relevance of Prx5, but 
not Prx3, to lifespan has been demonstrated in Droso-
phila melanogaster [23], a gain-of-function allele of 
peroxiredoxin (thioredoxin peroxidase, Tsa1p) reduces 
oxidative stress but stimulates premature aging in yeast 
[24]. Thus, further investigation is required to elucidate 
how H2O2 is regulated in mitochondria, as well as the 
role of this mechanism in aging in the heart. 
 
Nox4 is a major superoxide-producing enzyme 
localized in mitochondria in the cardiovascular 
system 
 
The NADPH oxidases are membrane-spanning proteins 
with NAD(P)H and FAD binding domains in their C-
terminal tails that produce O2
- by transferring an 
electron from NADPH (or NADH) to molecular oxygen 
[11]. The NADPH oxidase was thought to be a 
phagocyte-specific enzyme and to play a critical role in 
mediating bacterial killing by producing a burst of O2
- 
[10], until its family protein Nox1 was discovered in 
smooth muscle cells and colonic epithelium [25]. There 
are now 7 known proteins in the NADPH oxidase (Nox) 
family, i.e. Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and 
Duox2, which, with the exception of Nox2, were all 
identified in this decade [1, 10, 11]. The initial cloning 
paper reported that Nox4 was expressed highly in the 
kidney [26, 27]. However, in contrast to other Nox 
proteins that are expressed only in specific tissues or 
cells, Nox4 is ubiquitously expressed at high levels, 
including in cardiovascular systems, such as endothelial 
cells [28], smooth muscle cells [29], and cardiomyo-
cytes [12, 30]. As we discuss below, Nox4 has unique 
characteristics compared to the other members of the 
Nox family. In particular, its localization on intra-
cellular membranes, including mitochondria, makes it 
an important candidate for regulating mitochondrial oxi-
dative stress during aging in the heart. 
 
Mitochondrial localization of Nox4 in cardiomyo-
cytes 
 
Although Nox2, a prototypical NADPH oxidase, is 
localized primarily on the plasma membrane, Nox4 
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Although the intracellular localization of Nox4 remains 
controversial, Nox4 appears to be localized in mito-
chondria in mesangial cells [13] and cardiomyocytes 
[12], the nucleus [31] or endoplasmic reticulum [32] in 
vascular endothelial cells, and the plasma membrane, 
especially at focal adhesions, in vascular smooth muscle 
cells [33]. The subcellular localizations of Nox4 may be 
truly cell type-dependent. However, different results 
may also be due to the distinct specificities of Nox4 
antibodies used for analyses. 
 
In cardiomyocytes, Nox4 significantly affects the level 
of oxidative stress in mitochondria [12, 34]. Nox4 has a 
mitochondrial localization signal-like motif in the N-
terminal region, which potentially directs expression of 
Nox4 to mitochondria [12]. Furthermore, many redox-
sensitive mitochondrial proteins, including aconitase 
and components of Complex I and the MPTP, are 
significantly more oxidized in the mouse heart 
overexpressing Nox4, and less in the cardiac-specific 
Nox4 KO heart [12,34]. Thus, Nox4 not only produces 
O2
-, thereby directly contributing to oxidative stress in 
mitochondria, but also induces oxidative damage of 
mitochondrial proteins and causes leakage of O2
- from 
mitochondria, which triggers a response known as ROS-
induced ROS release [35]. Using cardiac-specific Nox4 
KO mice, we have shown recently that Nox4 is an 
important source of oxidative stress in mitochondria 
during cardiac hypertrophy and failure [34]. The results 
suggest that electron leakage may not be the sole source 
of oxidative stress in the heart and that Nox4 in 
mitochondria could be an active source under stress. 
Since expression of Nox4 is upregulated by cardiac 
stress, including pressure overload, heart failure and 
aging, upregulation of Nox4 may allow it to be a 
significant source of mitochondrial oxidative stress 
under stress conditions.  
 
The NADPH oxidases receive electrons from either 
NADPH or NADH and transfer them to molecular 
oxygen. The proto-type NADPH oxidase, Nox2, which 
is localized at the plasma membrane, utilizes NADPH 
as an electron donor [10]. During phagocytosis, the 
pentose-cycle supplying NADPH in the cytosol is 
drastically activated in phagocytes. In contrast, Nox4 
appears to utilize NADH as an electron donor to 
produce O2
-,
 at least in vitro assays [27,36,37]. Consis-
tently, NADH produces a greater amount of ROS than 
NADPH in mitochondria isolated from hearts overexpr-
essing Nox4 [12]. Since NADH is produced abundantly 
in the TCA cycle, Nox4 localized in mitochondria may 
directly utilize NADH derived from the TCA cycle to 
produce O2
-. Thus, an exciting hypothesis is that Nox4 
is an integral component of the mitochondrial TCA 
cycle and directly regulates the activity of NADH-
generating enzymes as a negative feedback mechanism. 
When the TCA cycle operates, the resultant generation 
of NADH may increase ROS production through Nox4, 
which could in turn suppress the activity of mitochondr-
ial proteins through oxidative modification.  
 
Aging, lifespan, and Nox4 
 
The localization of Nox4 in mitochondria and its 
upregulation during aging support the hypothesis that 
Nox4 plays an important role in mediating ROS 
production during aging and controlling the aging pro-
cess in the heart. Overexpression of Nox4 induces 
cellular senescence in fibroblasts [26, 27] and apoptosis 
in cardiomyocytes [12]. In vascular smooth muscle 
cells, Nox4 upregulation plays a causal role in medi-
ating the accumulation of polyploid cells, a biomarker 
of aging [38]. Cardiac-specific overexpression of Nox4 
in mice exacerbates aging-associated cardiac phenol-
types, such as left ventricular dysfunction, apoptosis, 
and fibrosis, accompanied by mitochondrial oxidative 
stress and dysfunction [12].   
 
If endogenous Nox4 is a major source of oxidative 
stress and mediates aging in the heart, it could become 
an ideal target for pharmacological interventions to 
prevent age-associated complications in the heart. It 
will, therefore, be important to evaluate the role of 
endogenous Nox4 and Nox4-derived ROS in mediating 
aging of the heart, using Nox4 KO mice. We expect that 
downregulation of Nox4 should reduce the amount of 
O2
- in mitochondria, thereby inhibiting the aging pro-
cess in the heart. On the other hand, since Nox4 
consumes NADH as an electron donor to produce O2
-, 
downregulation of Nox4 could lead to accumulation of 
NADH, a condition opposite from that induced by 
caloric restriction, an established intervention attenu-
ating aging. Thus, the overall effect of Nox4 down-
regulation upon aging could be more complex. 
Although Nox4 does not have an obvious SOD-like 
motif in its structure, recent evidence suggests that 
Nox4 may directly produce H2O2 rather than O 2
- [39, 
40]. If this observation is true, Nox4 may affect aging 
through production of H2O2. The involvement of spe-
cific ROS and the molecular mechanism mediating 
stimulation of aging by Nox4 in the heart remain to be 
elucidated. It should be noted that the mouse heart 
exhibits a remarkably negligible aging phenotype in 
response to Nox4 overexpression in young mice [12]. 
Increased expression of Nox4 in the heart upregulates 
antioxidants, such as catalase [12], indicating that the 
heart has adaptive mechanisms antagonizing the action 
of   Nox4.   Elucidating  these  mechanisms  would  also 
provide us with valuable information regarding  how  to 
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Effects of redox modification & Nox4 may be cell-
type dependent 
 
The effects of Nox4-derived ROS appear to be cell 
type-dependent. Nox4 stimulates apoptosis in endo-
thelial cells [41] and cardiomyocytes [12], while it 
induces cell proliferation in smooth muscle cells [42] 
and cardiac fibroblasts [12]. Although the molecular 
mechanisms through which Nox4 exerts different 
effects in different cell types are currently unknown, it 
is possible that ROS generated by Nox4 affect distinct 
targets in each cell type. Interestingly, the response of 
the heart to pressure overload differs substantially 
between “cardiomyocyte-specific” [34] and “global” 
[30] Nox4 KO mice. Although cardiomyocytes are the 
major cell type in the heart, the heart also consists of 
other cell types, including cardiac fibroblasts, endothel-
ial cells, and smooth muscle cells. The absence of Nox4 
differentially affects each cell type and, thus, the overall 
response of the heart differs when Nox4 is deleted only 
in cardiomyocytes from when it is deleted in every cell 
type. By inference, the role of Nox4 in regulating aging 
could differ from tissue to tissue, and the role of Nox4 
in regulating lifespan in the whole animal is probably 
complex. In this regard, the role of endogenous Nox4 in 
mediating aging in each organ should be addressed with 




Unlike other ROS-producing enzymes, the Nox family 
proteins produce O2
- and/or H2O2 purposefully in a 
regulated manner. Nox4 is localized in the peri-nuclear 
region, especially in mitochondria, in cardiomyocytes. 
Due to its close proximity to mitochondrial proteins, 
ROS generated by Nox4 oxidize mitochondrial proteins, 
which in turn trigger mitochondrial dysfunction and 
electron leakage. We speculate that when ROS 
production via Nox4 is beyond the capacity of 
antioxidants, ROS are accumulated in mitochondria, 
thereby triggering the aging process. Aging not only 
upregulates Nox4 but also downregulates antioxidant 
mechanisms in mitochondria. We speculate that, as in 
the failing heart, Nox4 could be an important source of 
mitochondrial oxidative stress in the aging heart. If 
Nox4 is shown to be involved in the aging process in 
the heart, it could be a promising target of pharmaco-
logical intervention because aging-induced cardiomyo-
pathy remarkably enhances the patient’s risk of develop-
ing heart failure in response to many cardiac conditions, 
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